Supplementary Figure 2 from BCL-2 Hypermethylation Is a Potential Biomarker of Sensitivity to Antimitotic Chemotherapy in Endocrine-Resistant Breast Cancer

Autor: Elizabeth A. Musgrove, Susan J. Clark, Cristin G. Print, Robert I. Nicholson, Julia M.W. Gee, Andrew V. Biankin, Christopher J. Ormandy, C. Elizabeth Caldon, David Gallego-Ortega, C. Marcelo Sergio, Rachael A. McCloy, Fatima Valdes-Mora, Mark J. Cowley, Andrew Stone
Rok vydání: 2023
DOI: 10.1158/1535-7163.22499787.v1
Popis: PDF - 664KB, BCL-2 Gene expression vs methylation status.
Databáze: OpenAIRE